The importance of T cells in DS-mediated anti-tumor effects was further corroborated by the finding that CD8+ T-cell depletion, achieved via a CD8-neutralizing antibody, abrogated DS’s anti-tumor efficacy (Fig. 3M and Fig. S4C and D). The gene discussed is CD8A; the disease is neoplasm.